McKesson Corp. engages in providing healthcare services. It operates through the following segments: U.S. Pharmaceutical, Prescription Technology Solutions (RxTS), Medical-Surgical Solutions ...

ClearBridge Investments, an investment management company, released its “ClearBridge Large Cap Value Strategy” third quarter ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

Furthermore, Coldwell notes that McKesson’s practice of providing guidance and explanations has become more opaque, especially in relation to its Medical-Surgical and Prescription Technology ...

McKesson (MCK) has recently been on Zacks.com's list of the most searched stocks. Therefore, you might want to consider some of the key factors that could influence the stock's performance in the near ...

McKesson Corporation was the highest-scoring large cap on the most recent Magic Formula screen for Oct. 2024. Click here to ...

Supported by world-class markets data from Dow Jones and FactSet, and partnering with Automated Insights, MarketWatch ...

Shares of McKesson (MCK) are oversold. They are also at a potential support level. Stocks that are oversold and at support tend to rally. The best traders traders focus on key price levels and ...

not keeping up with the Medical sector's loss of 3.6% and the S&P 500's gain of 1.21%. The investment community will be paying close attention to the earnings performance of McKesson in its ...

Baird downgraded medical distributor McKesson (NYSE:MCK) to neutral from outperform on Tuesday, calling the company's plans to conduct an investor event with the sell-side community "unusual." ...

McKesson Corporation (NYSE:MCK) shareholders might be concerned after seeing the share price drop 16% in the last quarter. But in stark contrast, the returns over the last half decade have ...